[Sinonasal cancers]

Area of Science:

• Oncology
• Head and Neck Surgery
• Rare Tumors

Background:

• Sinonasal cancers (SNC) are rare tumors within the head and neck cancer spectrum.
• SNC encompass diverse histological subtypes, complicating diagnosis and management.
• Physicians require enhanced awareness of diagnostic and therapeutic strategies for SNC.

Purpose of the Study:

• To increase physician awareness of sinonasal cancer diagnosis and treatment.
• To highlight functional consequences and long-term monitoring of SNC patients.
• To review current and emerging therapeutic options for SNC.

Main Methods:

• Review of histological entities within SNC.
• Discussion of advanced therapeutic modalities including endoscopic surgery, radiotherapy, and systemic treatments.
• Emphasis on the role of expert networks (REFCOR) and patient support associations (CORASSO).

Main Results:

• SNC require specialized diagnostic and therapeutic approaches due to their rarity and heterogeneity.
• New treatments like endoscopic surgery and advanced radiotherapy offer improved outcomes.
• Multidisciplinary collaboration through networks and associations is vital for comprehensive patient management.

Conclusions:

• Optimal management of sinonasal cancers necessitates heightened physician awareness and specialized care.
• Integration of novel surgical, radiological, and systemic therapies improves patient outcomes.
• Expert networks and patient support systems are essential for holistic SNC care.